The clinical effects of nifedipine on periodontal status.

The present study was conducted to determine the clinical effects of nifedipine on the gingiva of 97 patients. Patients were examined for changes in periodontal status and divided into subgroups, based on their age, gender, duration of drug intake, presence/absence of plaque and gingival inflammation, and according to the presence and severity of gingival overgrowth. Gingival overgrowth was noticed in 29% of the patients. Among the recorded parameters, duration of drug intake, presence/severity of gingival inflammation, and gender seemed to have the greatest effect on the development of gingival overgrowth. Patients with higher gingival inflammation scores, those on nifedipine medication for more than 4 years, and males were likely to have an increased tendency for higher incidence and severity of gingival overgrowth. The findings of the present study suggest that nifedipine medication induces gingival overgrowth and that certain local factors are involved in the pathogenesis of drug-induced gingival overgrowth. However, individual ability and sensitivity to metabolize the drug and its metabolites also seem to be important etiological factors.

[1]  J. R. Clay,et al.  Nifedipine-associated gingival overgrowth: a survey of the literature and report of four cases. , 1996, Quintessence international.

[2]  R. Seymour,et al.  Iatrogenic gingival overgrowth in cardiac transplantation. , 1995, Journal of periodontology.

[3]  Kelvin K. W. Lee,et al.  Prevalence of nifedipine-induced gingival hyperplasia. , 1995, Journal of periodontology.

[4]  T. Oka,et al.  Factors influencing nifedipine-induced gingival overgrowth in rats. , 1995, Journal of periodontology.

[5]  R. Looney,et al.  Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. , 1994, Clinical immunology and immunopathology.

[6]  F. O'Valle,et al.  Immunohistochemical study of 30 cases of cyclosporin A-induced gingival overgrowth. , 1994, Journal of periodontology.

[7]  M. Somacarrera,et al.  Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. , 1994, Journal of periodontology.

[8]  I. Morisaki,et al.  Nifedipine-induced gingival overgrowth in the presence or absence of gingival inflammation in rats. , 1993, Journal of periodontal research.

[9]  R. Walker,et al.  Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. , 1993, Journal of clinical periodontology.

[10]  R. Seymour,et al.  Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth , 1992, The Lancet.

[11]  R. Seymour,et al.  The incidence and severity of nifedipine-induced gingival overgrowth. , 1992, Journal of clinical periodontology.

[12]  C. McCulloch,et al.  Role of fibroblast subpopulations in periodontal physiology and pathology. , 1991, Journal of periodontal research.

[13]  J. Shupe,et al.  In vitro effect of chlorhexidine and amikacin on oral gram-negative bacilli from bone marrow transplant recipients. , 1990, Oral surgery, oral medicine, and oral pathology.

[14]  R. Corio,et al.  Nitrendipine-induced gingival hyperplasia. First case report. , 1990, Oral surgery, oral medicine, and oral pathology.

[15]  L. Heijl,et al.  Nitrendipine-induced gingival overgrowth in dogs. , 1989, Journal of periodontology.

[16]  J. Taylor,et al.  CYCLOSPORIN, NIFEDIPINE, AND GINGIVAL HYPERPLASIA , 1987, The Lancet.

[17]  J. Hiss,et al.  Gingival Hyperplasia Caused by Nifedipine , 1987 .

[18]  T. McGaw,et al.  Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. , 1987, Oral surgery, oral medicine, and oral pathology.

[19]  T. Daley,et al.  Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. , 1986, Oral surgery, oral medicine, and oral pathology.

[20]  L. Howell,et al.  Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. , 1985, Journal of periodontology.

[21]  W. Tyldesley,et al.  Gingival hyperplasia induced by cyclosporin-A , 1984, British Dental Journal.

[22]  H. Lumerman,et al.  Gingival hyperplasia associated with nifedipine therapy. Report of a case. , 1984, Oral surgery, oral medicine, and oral pathology.

[23]  S. Behar,et al.  Gingival hyperplasia caused by nifedipine--a preliminary report. , 1984, International journal of cardiology.

[24]  A.L. Russell,et al.  A System of Classification and Scoring for Prevalence Surveys of Periodontal Disease , 1956, Journal of dental research.

[25]  R. Seymour,et al.  The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. , 1993, Journal of clinical periodontology.

[26]  G. Romanos,et al.  Extracellular matrix analysis of nifedipine-induced gingival overgrowth: immunohistochemical distribution of different collagen types as well as the glycoprotein fibronectin. , 1993, Journal of periodontal research.

[27]  R. H. Hancock,et al.  Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque. , 1992, Journal of clinical periodontology.

[28]  T. Nagata,et al.  Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. , 1991, Journal of periodontology.

[29]  D. B. Gower,et al.  Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. , 1990, Journal of periodontal research.

[30]  R. Seymour,et al.  Drugs and the periodontium. , 1988, Journal of clinical periodontology.